Entellus Medical to Report Fourth Quarter and Year-End 2015 Financial Results on February 24, 2016
Conference Call Scheduled for Wednesday, February 24, 2016 at 4:30pm ET
PLYMOUTH, Minn., Feb. 10, 2016 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis patients, today announced that it will release its financial results for the fourth quarter and year-end 2015 after the close of trading on Wednesday, February 24, 2016. The Company’s management team will host a corresponding conference call beginning at 3:30pm CT/4:30pm ET to discuss the financial results and recent business developments. Individuals interested in listening to the conference call may do so by dialing (877) 930-5751 for domestic callers or (253) 336-7277 for international callers, using Conference ID: 38482495. To listen to a live webcast, please visit the investor relations section of the Entellus Medical website at: www.entellusmedical.com. A replay of the call will be available beginning February 24, 2016 at 6:30pm CT/7:30pm ET through midnight ET on February 25, 2016. To access the replay, dial (855) 859-2056 or (404) 537-3406 and reference Conference ID: 38482495. The webcast will also be available on the Entellus Medical website for one month following the completion of the call. About Entellus Medical, Inc. Contact: Lynn Pieper Lewis 415-309-5999 ir@entellusmedical.com |
|